Biogen Newsroom

Needham Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $285

Moomoo NewsAug 19 05:32 ET

Biogen Analyst Ratings

BenzingaAug 19 05:31 ET

Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Hyperfine (HYPR) and Biogen (BIIB)

TipRanksAug 11 13:03 ET

Mizuho Securities Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $251

Moomoo NewsAug 6 07:40 ET

Biogen Analyst Ratings

BenzingaAug 6 07:26 ET

Mizuho Maintains Outperform on Biogen, Lowers Price Target to $251

BenzingaAug 6 07:26 ET

Mizuho Adjusts Biogen's Price Target to $251 From $277, Keeps Outperform Rating

MT NewswiresAug 5 12:34 ET

Biogen Price Target Cut to $302.00/Share From $340.00 by Truist Securities

Dow JonesAug 5 09:56 ET

Truist Financial Maintains Biogen(BIIB.US) With Buy Rating, Announces Target Price $302

Moomoo NewsAug 5 07:34 ET

Needham Maintains Buy on Biogen, Lowers Price Target to $285

BenzingaAug 5 06:13 ET

Buy Rating Affirmed for Biogen Amid Strong Core Performance and Strategic Growth Initiatives

TipRanksAug 5 02:27 ET

Jefferies Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $250

Moomoo NewsAug 2 21:32 ET

Oppenheimer Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $270

Moomoo NewsAug 2 21:32 ET

Biogen Price Target Cut to $225.00/Share From $240.00 by Wells Fargo

Dow JonesAug 2 14:39 ET

Biogen Analyst Ratings

BenzingaAug 2 12:33 ET

A Quick Look at Today's Ratings for Biogen(BIIB.US), With a Forecast Between $215 to $300

Moomoo NewsAug 2 09:04 ET

Buy Rating Affirmed: Biogen's Growth Momentum and Strategic Developments Fuel Positive Outlook

TipRanksAug 2 08:31 ET

Wedbush Adjusts Price Target on Biogen to $210 From $215

MT NewswiresAug 2 08:02 ET

Truist Financial Keeps Their Buy Rating on Biogen (BIIB)

TipRanksAug 2 07:51 ET

Optimistic Outlook on Biogen's Leqembi for Alzheimer's: Buy Rating Justified by EMA Prospects and Positive Long-Term Data

TipRanksAug 2 06:36 ET